Determinants of survival following HIV-1 seroconversion after the introduction of HAART
Cascade Collaboration - The Lancet, 2003 - thelancet.com
Background Highly active antiretroviral therapy (HAART) was introduced in 1997. We aimed
to assess the continuing effect of this treatment on survival and progression to AIDS after HIV …
to assess the continuing effect of this treatment on survival and progression to AIDS after HIV …
Survival after introduction of HAART in people with known duration of HIV-1 infection
Cascade Collaboration - The Lancet, 2000 - Elsevier
We compared survival from HIV-1 seroconversion before and during the periods of highly-
active antiretroviral therapy (HAART). Survival expectations were substantially better for HIV …
active antiretroviral therapy (HAART). Survival expectations were substantially better for HIV …
Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on …
A Babiker, S Darby, D De Angelis, D Kwart, K Porter… - Lancet, 2000 - ora.ox.ac.uk
BACKGROUND: We used data from Europe, North America, and Australia to assess the
effect of exposure category on the AIDS incubation period and HIV-1 survival and whether …
effect of exposure category on the AIDS incubation period and HIV-1 survival and whether …
Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion
Cascade Collaboration - Aids, 2006 - journals.lww.com
Methods: Twenty-two cohorts of HIV-infected individuals with known dates of seroconversion
are pooled in the CASCADE collaboration. Causes of death (COD) were categorized into …
are pooled in the CASCADE collaboration. Causes of death (COD) were categorized into …
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies
Antiretroviral Therapy (ART) Cohort Collaboration - Aids, 2007 - journals.lww.com
Objective: To estimate the prognosis over 5 years of HIV-1-infected, treatment-naive patients
starting HAART, taking into account the immunological and virological response to therapy …
starting HAART, taking into account the immunological and virological response to therapy …
Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category
S Pérez-Hoyos, J Del Amo, R Muga, J Del Romero… - Aids, 2003 - journals.lww.com
Objective: To evaluate the population effectiveness of highly active antiretroviral therapy
(HAART) in HIV progression and determine the heterogeneity of the effect of HAART in …
(HAART) in HIV progression and determine the heterogeneity of the effect of HAART in …
Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984–2004
Objective: To characterize changing survival patterns after development of clinical AIDS from
1984 to 2004, when different antiretroviral therapies were being introduced. Design: Cohort …
1984 to 2004, when different antiretroviral therapies were being introduced. Design: Cohort …
Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy
KE Poundstone, RE Chaisson, RD Moore - Aids, 2001 - journals.lww.com
Background The advent of highly active antiretroviral therapy (HAART) has reduced the
incidence of most AIDS-related opportunistic illnesses (OI) and death in HIV-infected …
incidence of most AIDS-related opportunistic illnesses (OI) and death in HIV-infected …
Mortality and progression to AIDS after starting highly active antiretroviral therapy
Objectives: To examine survival and progression to AIDS among HIV-infected patients after
starting highly active antiretroviral therapy (HAART). Methods: The study population …
starting highly active antiretroviral therapy (HAART). Methods: The study population …
Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy
Objectives: To estimate survival patterns after HIV infection in adults in low and middle-
income countries. Design: An analysis of pooled data from eight different studies in six …
income countries. Design: An analysis of pooled data from eight different studies in six …